Sponsor: GenScript ProBioIn this GEN webinar, we will hear how GenScript ProBio aids the biopharma industry as it continues to develop and optimize processes for GMP plasmids, lenti, and AAV viral vector manufacturing.
Sponsor: TriLink BiotechnologiesIn this GEN webinar, Dr. Wen Xue will present a modular delivery strategy for homology-directed repair by combining lipid nanoparticle delivery of Cas9 mRNA with adeno-associated viruses (AAV) encoding a sgRNA and a repair template.
Sponsor: TecanJoin us for Episode 4 of GEN Live, sponsored by Tecan. In this live zoom event we discuss the state of vaccine development for COVID-19. We evaluate the front-runners, explore the potential of RNA vaccines, ponder the challenges of manufacturing, and tackle questions about herd immunity.
Cleft palates. Grievous wounds. Lost hands or faces. All could be repaired more completely than is currently possible if genetic editing were to become...
Synthego says the $110 million in Series C financing it raised this week will enable it to proceed with ambitious expansion plans that include...
Virus particles that infect bacteria can work together to overcome antiviral defences, new research shows.
A technology designed to improve CRISPR-Cas9 gene editing in mosquitoes and other arthropods succeeds with a high degree of efficiency, while eliminating the need for difficult microinjection of genetic material, according to researchers.
Team invents biological switch that turns protein expression on at will
Team uses mRNA-loaded carriers to target the genetic instructions of an anti-inflammatory protein in immune cells.
Researchers detail the binding domain of BurrH, a DNA-binding protein. They also reprogrammed the domain, called BuD, showing its potential as a gene-editing tool.